• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对终末期肾病病因的进一步认识。

An improved understanding of the causes of end-stage renal disease.

作者信息

Young E W

机构信息

Nephrology Section, VA Medical Center, Ann Arbor, MI 48105, USA.

出版信息

Semin Nephrol. 1997 May;17(3):170-5.

PMID:9165646
Abstract

An understanding of the causes of end-stage renal disease (ESRD) is approached through a discussion of currently attributed causes, potentially unattributed causes, and the reasons for growth in new ESRD cases. The attributed causes of ESRD have varied over time and by region. In the United States, diabetes has long been the most common attributed cause of ESRD, accounting for 36% of incident cases in 1992. In contrast, diabetic ESRD is far less common in other countries. Hypertension and glomerulonephritis are the next most commonly attributed causes of ESRD, but these diagnoses are not necessarily based on consistent or uniform criteria. Mistaken classification of the cause of ESRD is possible in many cases. Emerging evidence suggests that other processes, including renovascular disease and analgesic ingestion, can cause or contribute to ESRD more often than they are recorded. The incidence of ESRD has been increasing at a rate of up to 9% per year. The likely reasons for ESRD growth include decreased competing risk from other diseases, increased referral and acceptance of patients with advanced renal failure, and increased renal disease.

摘要

通过讨论目前已知的病因、可能未被归因的病因以及终末期肾病(ESRD)新发病例增加的原因,来深入了解ESRD的病因。ESRD的已知病因随时间和地区的不同而有所变化。在美国,糖尿病长期以来一直是ESRD最常见的已知病因,在1992年占新发病例的36%。相比之下,糖尿病性ESRD在其他国家则要少见得多。高血压和肾小球肾炎是ESRD接下来最常见的已知病因,但这些诊断不一定基于一致或统一的标准。在许多情况下,ESRD病因的错误分类是可能的。新出现的证据表明,其他一些病症,包括肾血管疾病和止痛药摄入,导致或促成ESRD的频率可能比记录的更高。ESRD 的发病率一直以每年高达9%的速度增长。ESRD病例增加的可能原因包括其他疾病的竞争风险降低、晚期肾衰竭患者转诊和收治的增加以及肾病的增多。

相似文献

1
An improved understanding of the causes of end-stage renal disease.对终末期肾病病因的进一步认识。
Semin Nephrol. 1997 May;17(3):170-5.
2
Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States.美国因肾血管疾病导致的终末期肾病的发病率趋势和死亡率
Am J Kidney Dis. 2001 Jun;37(6):1184-90. doi: 10.1053/ajkd.2001.24521.
3
Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.1998 - 2002年欧洲、加拿大及亚太地区20 - 64岁人群中接受治疗的终末期肾病发病率趋势,总体及按原发性肾病分类的发病率趋势
Nephrology (Carlton). 2007 Oct;12(5):520-7. doi: 10.1111/j.1440-1797.2007.00830.x.
4
Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.1983 - 2000年日本终末期肾病发病率趋势:按性别和病因划分的年龄调整率和特定年龄率。
Nephrol Dial Transplant. 2004 Aug;19(8):2044-52. doi: 10.1093/ndt/gfh317. Epub 2004 Jun 1.
5
Different regional dynamics of end-stage renal disease in Japan by different causes.日本不同病因导致的终末期肾病的不同区域动态。
Nephrology (Carlton). 2005 Aug;10(4):400-4. doi: 10.1111/j.1440-1797.2005.00404.x.
6
Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.优化糖尿病患者的终末期肾病治疗
Semin Nephrol. 1997 Jul;17(4):331-45.
7
Incidence of end-stage renal disease among persons with diabetes--United States, 1990-2002.1990 - 2002年美国糖尿病患者中终末期肾病的发病率
MMWR Morb Mortal Wkly Rep. 2005 Nov 4;54(43):1097-100.
8
Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study.糖尿病肾病作为埃及终末期肾病的一个病因:一项为期六年的研究。
East Mediterr Health J. 2004 Jul-Sep;10(4-5):620-6.
9
Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.解读接受治疗的终末期肾病的发病率趋势:对评估澳大利亚疾病控制情况的启示
Nephrology (Carlton). 2004 Aug;9(4):238-46. doi: 10.1111/j.1440-1797.2004.00259.x.
10
Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.1998 - 2002年欧洲、加拿大及亚太地区终末期肾病发病率的地理、种族、年龄相关及时间变化
Nephrol Dial Transplant. 2006 Aug;21(8):2178-83. doi: 10.1093/ndt/gfl145. Epub 2006 Apr 4.

引用本文的文献

1
Comparing the values of intact parathormone and 1- 84 PTH to predict hyperparathyroidism in hemodialysis patients.比较完整甲状旁腺激素和1-84甲状旁腺激素的值以预测血液透析患者的甲状旁腺功能亢进。
J Nephropathol. 2017 Jul;6(3):248-253. doi: 10.15171/jnp.2017.40. Epub 2017 Apr 22.
2
Changing trends in the referral patterns of pediatric nephrology patients.儿科肾病患者转诊模式的变化趋势
Pediatr Nephrol. 2005 May;20(5):603-8. doi: 10.1007/s00467-004-1750-3. Epub 2005 Mar 17.